Cobar, Freya Venventia .

HRN: 21-22-12  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/29/2022
06/04/2022
IVT
40mg
Q24
Pcap C
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: